 |
|
Systemic Infection Following BCG Therapy
Eugene B. Rosenberg, MD;
Steven P. Kanner, MD;
Robert J. Schwartzman, MD;
Jacob Colsky, MD
Arch Intern Med. 1974;134(4):769-770.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
BCG vaccination has been widely used for tuberculosis prophylaxis, and complications in normal individuals have rarely been reported.1 Recently, there has been widespread interest in the use of BCG vaccine as immunotherapy in patients with cancer. This therapy, however, may lead to serious complications.2 A patient with malignant melanoma who received multiple BCG injections illustrates the occurrence of systemic BCG infection in an anergic individual.
Patient Summary
A 61-year-old white man was diagnosed as having malignant melanoma by biopsy in 1963. At that time, the melanoma was localized to the patient's right leg, and he underwent a surgical resection with node dissection. He remained free of detectable disease for seven years. Two years before admission, he developed recurrent melanoma in the right leg. Some lesions were surgically removed, and the patient received two courses of chemotherapy with dimethyltriazeno imidazole carboxamide and bis-chlorethyl nitrosourea with no apparent effect
. . . [Full Text PDF of this Article]
Author Affiliations
From the divisions of Medical Oncology and Nuclear Medicine, University of Miami School of Medicine, Miami, Fla.
Footnotes
Received for publication Nov 19, 1973; accepted Feb 26, 1974.
Reprint requests to Division of Nuclear Medicine, Room N-2042, Mount Sinai Hospital, 4300 Alton Rd, Miami Beach, FL 33140 (Dr. Rosenberg).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
